FDA Approves New Drug To Alleviate Moderate To Severe Pain

Main Category: Pain / Anesthetics
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 26 Nov 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (3 votes)

Healthcare Prof:5 stars

5 (1 votes)

Article Opinions: 1 posts

The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain.

Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100 mg.

"This approval offers health care professionals an additional choice for treating moderate to severe acute pain," said John Jenkins, M.D., director of the office of new drugs in the FDA's Center for Drug Evaluation and Research.

Tapentadol acts in two ways, opioid (narcotic) and non-opioid. It affects the brain and body primarily by activating opioid receptors in the brain, spinal cord and gastrointestinal tract. In addition, Tapentadol inhibits the reuptake of the brain chemical norepinephrine which possibly has an analgesic effect.

Acute pain is a symptom of many medical conditions and can significantly interfere with a person's quality of life and general functioning. Opioids are considered safe and effective in selected patients but can cause dependence, abuse, and addiction. All patients treated with opioids require careful monitoring by their health care professional for signs of abuse and addiction, and to determine when opioid analgesics are no longer needed.

The most common side effects from Tapentadol are nausea, dizziness, vomiting, and sleepiness. The labeling for Tapentadol includes warnings about the risk of respiratory depression; addictive depressive effects on the central nervous system when taken with alcohol, other opioids, or illicit drugs; and abuse potential.

Tapentadol is manufactured by Janssen Ortho, LLC, Gurabo, PR.

http://www.fda.gov

What are Opioids?

For more information on what opioids are, and opioid-induced constipation (OIC), please see:
All About Opioids and Opioid-Induced Constipation (OIC)

What is pain?

For more information on what pain is and possible treatments, please see:
What is Pain? What Causes Pain?

Article adapted by Medical News Today from original press release.
Visit our pain / anesthetics section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
FDA. "FDA Approves New Drug To Alleviate Moderate To Severe Pain." Medical News Today. MediLexicon, Intl., 26 Nov. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/130879.php>

APA
FDA. (2008, November 26). "FDA Approves New Drug To Alleviate Moderate To Severe Pain." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/130879.php.

Please note: If no author information is provided, the source is cited instead.


Pain / Anesthetics

Opioids and Opioid-Induced Constipation (OIC)

Opioids are a class of drugs that are commonly prescribed for their analgesic, or pain-killing, properties. They include substances such as morphine, codeine, oxycodone, and methadone. Opioids may be more easily recognized by drug names such as Kadian... Read more...

Most Popular Articles



Follow Our Pain News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pain / Anesthetics Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »